{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.464.1003.110.11.1065","meta":{"versionId":"35","lastUpdated":"2021-09-14T01:00:46.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1065","version":"20210914","name":"DTaP Vaccine Administered","status":"active","date":"2021-09-14T01:00:46-04:00","publisher":"NCQA PHEMUR","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"90697","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"},{"code":"90698","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use"},{"code":"90700","display":"Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), when administered to individuals younger than 7 years, for intramuscular use"},{"code":"90723","display":"Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use"}]}]}}